Literature DB >> 19916816

Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?

Audrey K Housel1, Nancee Waterbury, Tami R Argo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19916816     DOI： 10.3109/01612840903276712

Source DB:  PubMed          Journal:  Issues Ment Health Nurs        ISSN： 0161-2840            Impact factor:   1.835


× No keyword cloud information.
  1 in total

Review 1.  Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.

Authors:  Chuanjun Zhuo; Yong Xu; Sha Liu; Jing Li; Qishi Zheng; Xiangyang Gao; Shen Li; Rixing Jing; Xueqin Song; Weihua Yue; Chunhua Zhou; Rachel Upthegrove
Journal:  Front Pharmacol       Date:  2018-11-28       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.